Aviva
QGENF

Aviva’s QIAGEN NV QGENF Stock Holding History

Aviva’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-195,467
Closed -$5.52M – 773
2016
Q4 		$5.52M Buy
195,467
+4,086
+2% +$115K 0.03% 537
2016
Q3 		$5.26M Sell
191,381
-3,969
-2% -$109K 0.03% 536
2016
Q2 		$4.23M Buy
195,350
+53,570
+38% +$1.16M 0.03% 559
2016
Q1 		$3.14M Buy
141,780
+4,057
+3% +$89.8K 0.02% 617
2015
Q4 		$3.8M Sell
137,723
-280
-0.2% -$7.73K 0.03% 573
2015
Q3 		$3.57M Sell
138,003
-10,310
-7% -$267K 0.03% 585
2015
Q2 		$3.68M Buy
148,313
+15,520
+12% +$385K 0.03% 613
2015
Q1 		$3.35M Sell
132,793
-1,386,937
-91% -$34.9M 0.02% 665
2014
Q4 		$35.5M Sell
1,519,730
-53,265
-3% -$1.24M 0.28% 87
2014
Q3 		$35.9M Sell
1,572,995
-21,081
-1% -$481K 0.28% 81
2014
Q2 		$38.6M Sell
1,594,076
-4,727
-0.3% -$114K 0.3% 77
2014
Q1 		$33.6M Sell
1,598,803
-30,700
-2% -$645K 0.27% 87
2013
Q4 		$38.1M Buy
1,629,503
+449,304
+38% +$10.5M 0.32% 73
2013
Q3 		$24.4M Buy
1,180,199
+97,208
+9% +$2.01M 0.21% 117
2013
Q2 		$21.6M Buy
+1,082,991
New +$21.6M 0.22% 124

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Aviva's QGENF Position: Q1 2017 in Review

Aviva sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 195,467 shares — an estimated $5.52M sold.

Aviva first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $38.6M in Q2 2014. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Aviva reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Aviva sold 195,467 QIAGEN NV shares in Q1 2017, an estimated $5.52M.
  • Aviva first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • Aviva's QIAGEN NV position peaked at $38.6M in Q2 2014.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Aviva's 13F filing for Q1 2017, filed 15 May 2017.